"Intravitreal Injections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.
Concept/Terms
Intravitreal Injections- Intravitreal Injections
- Injection, Intravitreal
- Injections, Intravitreal
- Intravitreal Injection
Below are MeSH descriptors whose meaning is more general than "Intravitreal Injections".
Below are MeSH descriptors whose meaning is more specific than "Intravitreal Injections".
This graph shows the total number of publications written about "Intravitreal Injections" by people in Harvard Catalyst Profiles by year, and whether "Intravitreal Injections" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 2 | 2 |
| 2011 | 0 | 16 | 16 |
| 2012 | 1 | 11 | 12 |
| 2013 | 1 | 11 | 12 |
| 2014 | 3 | 16 | 19 |
| 2015 | 2 | 33 | 35 |
| 2016 | 3 | 17 | 20 |
| 2017 | 0 | 21 | 21 |
| 2018 | 1 | 25 | 26 |
| 2019 | 1 | 24 | 25 |
| 2020 | 0 | 18 | 18 |
| 2021 | 0 | 15 | 15 |
| 2022 | 0 | 22 | 22 |
| 2023 | 0 | 5 | 5 |
Below are the most recent publications written about "Intravitreal Injections" by people in Profiles.
-
CATASTROPHIC, BILATERAL RETINAL VASCULAR OCCLUSION AFTER INTRAVITREAL BEVACIZUMAB INJECTION. Retin Cases Brief Rep. 2023 Mar 01; 17(2):81-84.
-
Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy. JAMA. 2023 02 07; 329(5):376-385.
-
A root cause analysis to identify the mechanistic drivers of immunogenicity against the anti-VEGF biotherapeutic brolucizumab. Sci Transl Med. 2023 02; 15(681):eabq5068.
-
Anti-brolucizumab immune response as one prerequisite for rare retinal vasculitis/retinal vascular occlusion adverse events. Sci Transl Med. 2023 02; 15(681):eabq5241.
-
Controversies and Disparities in the Management of Age-Related Macular Degeneration. Semin Ophthalmol. 2023 Feb; 38(2):134-142.
-
Global Disparities in Retinopathy of Prematurity: A Literature Review. Semin Ophthalmol. 2023 Feb; 38(2):151-157.
-
Comparison in Retreatments between Bevacizumab and Ranibizumab Intravitreal Injections for Retinopathy of Prematurity: A Multicenter Study. Ophthalmology. 2023 Apr; 130(4):373-378.
-
Transition from Laser to Intravitreal Injections for Diabetic Retinopathy: Hospital Utilization and Costs from an Extended Healthcare Perspective. Int J Environ Res Public Health. 2022 10 02; 19(19).
-
COMBINED PNEUMATIC AND ENZYMATIC VITREOLYSIS FOR SEVERE CASES OF VITREOMACULAR TRACTION. Retin Cases Brief Rep. 2022 Sep 01; 16(5):631-636.
-
Color Vision and Microperimetry Changes in Nonexudative Age-Related Macular Degeneration After Risuteganib Treatment: Exploratory Endpoints in a Multicenter Phase 2a Double-Masked, Randomized, Sham-Controlled, Crossover Clinical Trial. Ophthalmic Surg Lasers Imaging Retina. 2022 08; 53(8):430-438.